Pharma News
-
What is the current valuation of AstraZeneca’s Sabestomig
The revenue for Sabestomig is expected to reach an annual total of $17 mn by 2039 in the US based…
Read More » -
What is the current valuation of AbbVie’s ABBV-400
The revenue for ABBV-400 is expected to reach an annual total of $38 mn by 2039 in the US based…
Read More » -
What is the current valuation of Merck’s MK-1084
The revenue for MK-1084 is expected to reach an annual total of $6 mn by 2038 in the US based…
Read More » -
What is the current valuation of AstraZeneca’s AZD-9574
The revenue for AZD-9574 is expected to reach an annual total of $18 mn by 2037 in the US based…
Read More » -
What is the current valuation of Novartis’s XXB-750
The revenue for XXB-750 is expected to reach an annual total of $21 mn by 2039 in the US based…
Read More » -
What is the current valuation of Novo Nordisk’s NNC0519-0130
The revenue for NNC0519-0130 is expected to reach an annual total of $10 mn by 2037 in the US based…
Read More » -
What is the current valuation of Eli Lilly and Co’s LY-3972406
The revenue for LY-3972406 is expected to reach an annual total of $16 mn by 2037 in the US based…
Read More » -
What is the current valuation of Pfizer’s PF-07275315
The revenue for PF-07275315 is expected to reach an annual total of $17 mn by 2038 in the US based…
Read More » -
Health Advocate Partners with Tava Health to Increase Access to Teletherapy
Tava’s network of therapists will be added to Health Advocate’s existing network. Source link #Health #Advocate #Partners #Tava #Health #Increase…
Read More » -
What is the current valuation of Enliven Therapeutics’s ELVN-002
The revenue for ELVN-002 is expected to reach an annual total of $12 mn by 2037 in the US based…
Read More »